The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Primary cytoreductive surgery with or without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: The OVHIPEC-2 trial in progress.
 
Ruby M. van Stein
No Relationships to Disclose
 
Simone N. Koole
No Relationships to Disclose
 
Karolina Sikorska
No Relationships to Disclose
 
Desmond P. Barton
No Relationships to Disclose
 
Lewis Perrin
No Relationships to Disclose
 
Donal Brennan
No Relationships to Disclose
 
Oliver Zivanovic
(OPTIONAL) Uncompensated Relationships - UpToDate
 
Berit J. Mosgaard
No Relationships to Disclose
 
Anna Fagotti
Speakers' Bureau - MSD; PharmaMar
 
Pierre-Emmanuel Colombo
No Relationships to Disclose
 
Valesca P. Retel
Research Funding - Agendia (Inst)
 
Gabe S. Sonke
Consulting or Advisory Role - Novartis (Inst)
Research Funding - AstraZeneca (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Roche (Inst)
 
Willemien J. Van Driel
No Relationships to Disclose